Description

This issue of Vital Signs, released on June 2, 2008, provides an strategic overview of issues surrounding the growth of microRNA research and use in drug discovery. Additionally, a company spotlight is provided for Miragen Therapeutics, Inc., a biopharmaceutical company seeking to develop medicines based on regulating microRNA. Reimbursement and regulatory news from the FDA is also provided for the week of May 19 - May 23, 2008.